Featured Events:

ChinaBio® Partnering Forum 2020
August 25–27, 2020
Delivered Digitally, China Standard Time
Registration is now open!

ChinaBio® Partnering Forum has grown to be the premier life science partnering conference in China since 2009. This year is our 12th anniversary, and for the first time will be delivered digitally! Going virtual will enable participants to hold meetings 24/7 using EBD Group's partneringONE® system, and to see the company presentations, keynote panels and workshops throughout the event. Join us this year for what will prove to be a dynamic and exciting event that will enable you to meet with colleagues from around the world, and to hear from executives, investors and industry experts from leading Chinese and global companies, as well as innovative startups.


Written by Richard Daverman, PhD, Executive Editor, Greg B. Scott.

Recent
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010

Click a link below to view the mailing archive as if it had been sent to you.

2020-07-03 01:30CapitalBio Raises $113 Million in Pre-IPO Round for Molecular Diagnostics and more...
2020-07-02 01:30SciClone Acquires China Rights to Immunotherapy in $120+ Million Deal and more...
2020-07-01 01:30Hygeia Healthcare Stages $282 Million Hong Kong IPO for Radiotherapy Services and more...
2020-06-30 01:30Gan & Lee Raises $360 Million in Shanghai IPO; Trades up 44% and more...
2020-06-28 01:30Week in Review: VistaGen Out-Licenses China/Asia Rights for Novel Anxiety Drug to EverInsight in $177 Million Deal
2020-06-27 01:30Chi-Med Raises $100 Million in Private Placement for Cancer Drugs and more...
2020-06-26 01:30VistaGen Signs $177 Million Deal with EverInsight for China/Asia Rights to VistaGen's Anxiety Drug
2020-06-25 01:30Sophonix of Beijing Closes $14 Million Round for Point-of-Care-Tests and more...
2020-06-24 01:30Genor Signs $46 Million In-licensing Deal for Breast Cancer Candidate and more...
2020-06-23 01:30SinocellTech Closes $181 Million IPO on STAR Board; Triples in Initial Trading and more...
2020-06-21 01:30Week in Review: Six China Biopharma Deals Raise a Total of $255 Million
2020-06-20 01:30Clover Bio Starts Phase I Trial of Trimer-Tag COVID-19 Vaccine and more...
2020-06-19 01:30Engrail Raises $32 Million From Nan Fung to In-license Neurological Drugs and more...
2020-06-18 01:30Shenzhen Immvira Completes $58 Million Funding for Oncolytic Virus Therapies and more...
2020-06-17 01:30Miaoshou Doctor Closes $85 Million Funding for Online-Offline Health Services and more...
2020-06-16 01:30Cygnus Bioscience Raises $14 Million for Gene Sequencing Machines and more...
2020-06-13 01:30Burning Rock Raises $223 Million In US IPO; Climbs 50% in Trading and more...
2020-06-12 01:30Simcere Plans to Raise a Rumored $500 Million in Hong Kong IPO and more...
2020-06-11 01:30JW Therapeutics Raises $100 Million to Support CAR-T Portfolio and more...
2020-06-10 01:30Suzhou Innovent Signs $2 Billion-plus Bi-Specific/CAR-T Development Deal with Roche and more...
2020-06-09 01:30MabPlex Raises $71 Million for Biopharmaceutical CDMO Services and more...
2020-06-07 01:30Week in Review: China Life Science Companies Raise Nearly $1 Billion Led by Legend's $424 Million US IPO
2020-06-06 01:30Everest Medicines of Shanghai Closes $310 Million C Round for In-licensed Drugs and more...
2020-06-05 01:30BeiGene Approved to Launch BTK Inhibitor in China for Two Cancer Indications
2020-06-04 01:30Deep Informatics++ Closes $14 Million Series B for AI-based Pathology Products and more...
2020-06-03 01:30Jiangsu Atom Raises $30 Million to Support Global Trial of Gout Drug and more...
2020-06-02 01:30Nanjing Legend Biotech Plans to Raise $350 Million in US IPO at $2.6 Billion Valuation and more...

Please enter all required fields Click to hide
Correct invalid entries Click to hide
 

Subscribe >>


Not a ChinaBio®Today Subscriber?

Here's what you get with a paid subscription to ChinaBio® Today:
  • Website access to all current articles and commentary
  • Full access to over 2000 archived articles on the biotech industry

Greg B. Scott
Executive Editor
ChinaBio® Today


ChinaBio and ChinaBio Today are trademarks of ChinaBio LLC